SCHEMBL11023229

SCHEMBL11023229

Cc1ccccc1-c1c(Cl)cccc1OCCCCCCCCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.57
HPGD P15428 3/20 0.57
TSHR P16473 3/20 0.57
NPC1 O15118 1/20 0.57
L3MBTL1 Q9Y468 4/20 0.53
MAPT P10636 3/20 0.50
ALDH1A1 P00352 2/20 0.50
ALOX15 P16050 1/20 0.50
ALOX12 P18054 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
HSD17B10 Q99714 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 2/20 0.46
DRD2 P14416 1/20 0.45
DRD4 P21917 1/20 0.45
DRD3 P35462 1/20 0.45
MAOB P27338 1/20 0.45
ACHE P22303 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11018700 0.89 RAB9A (0.64) RAB9AHPGDTSHRNPC1L3MBTL1
SCHEMBL11021740 0.87 RAB9A (0.64) RAB9AHPGDTSHRNPC1L3MBTL1
SCHEMBL11020150 0.84 HPGD (0.68) RAB9AHPGDTSHRNPC1L3MBTL1
SCHEMBL11024159 0.84 MAOB (0.48) RAB9AHPGDTSHRNPC1L3MBTL1
SCHEMBL15923096 0.84 HPGD (0.81) RAB9AHPGDTSHRNPC1L3MBTL1
SCHEMBL11021052 0.83 HPGD (0.66) RAB9AHPGDTSHRNPC1L3MBTL1
SCHEMBL11021329 0.82 L3MBTL1 (0.43) RAB9AHPGDTSHRNPC1L3MBTL1
SCHEMBL10678991 0.82 RAB9A (0.61) RAB9AHPGDTSHRNPC1L3MBTL1
SCHEMBL10676300 0.82 HPGD (0.64) RAB9AHPGDTSHRNPC1L3MBTL1
SCHEMBL10679823 0.81 HPGD (0.56) RAB9AHPGDTSHRNPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0157652-A1 2-, 3- And 4-biphenyloxyaminoalkanes and related compounds, their preparation and uses, and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1985-10-09 EP disclosed